Neuroendocrine Prostate Cancer Subtype Is Aggressive and More Common Than Expected

Elisa Becze BA, ELS, Editor


Nearly 20% of men with metastatic, castration-resistant prostate cancer had tumors that developed into the treatment-emergent small-cell neuroendocrine (t-SCNC) subtype, which is associated with shorter survival than other subtypes, according to findings from a study published in theĀ Journal of Clinical Oncology.

View Article @

ONS Articles

Dive into a rich source of oncology nursing expertise with ONS articles.

View All Articles